SUSTAIN 340B Act proposes major changes for hospitals and pharmacies
A bipartisan working group in Congress released a preliminary legislative draft that attempts to resolve some of the most disputed aspects of the 340B Drug Pricing Program. One noteworthy provision in the legislation would curtail the 340B rebate model, which was finalized by the Health Resources and Services Administration on July 31 and is scheduled to begin Jan.…
Healthcare price transparency legislation gains momentum in Congress
Price transparency bills continue to be a focus in Congress as an area to pursue in possible year-end healthcare legislation. Two House committees and a Senate committee approved bills within the past two weeks. Among various other healthcare bills that have made it out of the committees are: There was significant bipartisan support at the…
Trump’s big bill’s beauty is in the eye of the beholder
HFMA Senior Editor Nick Hut talks with policy directors Shawn Stack and Andrew Donahue about the hospital impact of the Big Beautiful Bill. Garett Jackson from Intuitive Health talks about a hybrid emergency department/urgent care model to cut down on ED overuse.
2025-2026 healthcare policies timeline
The Trump administration and the Republican-led Congress have launched a flurry of healthcare initiatives and proposals since their first days. To help readers keep track of the wave of initiatives, below is a timeline of federal actions and our related coverage. All dates below are for 2025, unless marked “2026.” Executive Actions Jan. 17: Trump…
Congress seeks to keep the momentum going on improvements to prior authorization
Members of Congress are revitalizing efforts to pass legislation that would streamline prior authorization in Medicare Advantage (MA). A bipartisan, bicameral group of legislators reintroduced the Improving Seniors’ Timely Access to Care Act, a bill that unanimously passed the House in September 2022 but did not receive a vote in the Senate. One obstacle at…
Health system CEO tells Congress proposed 340B changes would be harmful to organizations like his
A health system executive visited Capitol Hill recently to provide the hospital perspective on the 340B Drug Pricing Program — a viewpoint that increasingly is coming under fire among policymakers. Matthew Perry, president and CEO of Genesis HealthCare System in Zanesville, Ohio, appeared at a House subcommittee hearing June 4 to give insight on why…
The FY24 HHS budget covers key programs for rural hospitals while tightening spending in some areas
The newly passed budget covering HHS during the remainder of FY24 contains notable provisions for healthcare providers. The roughly $117 billion departmental budget for the next six months was set in an appropriations bill that was passed by Congress and signed by President Joe Biden within hours of the March 22 expiration of funding for…
Site-neutral payment has backing in healthcare policy circles, but its efficacy as a cost restraint is unclear
The concept of site-neutral payment continues to receive support from members of Congress and healthcare policy analysts, as demonstrated during a recent hearing. The Jan. 31 hearing of the House Energy and Commerce Committee’s Health Subcommittee was intended, in part, to promote pending legislation that would strengthen price transparency and implement other policies designed to…
In Congress, it’s status quo for Medicaid DSH payments and the Medicare physician fee schedule
Yet another short-term federal funding measure from Congress included yet another brief extension of full funding for Medicaid disproportionate share hospital (DSH) payments. With funding for much of the federal government set to expire Jan. 19, Congress agreed on a continuing resolution that keeps all agencies fully operational until March. Medicaid DSH payments are guaranteed…
The big picture for healthcare in 2024, with Andrew Donahue
HFMA Policy Director Andrew Donahue discusses what trends and policy decisions will affect the healthcare industry in this election year.